Citadel Fine Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Madras-42., Tamil Nadu, India, established in 1966.
1966 Madras-42., Tamil Nadu, India Active
Last Updated:
Access Report
About Citadel Fine Pharmaceuticals Private Limited

Citadel Fine Pharmaceuticals Private Limited, a active private limited company, was established on 06 August 1966 in Madras-42., Tamil Nadu, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24231TN1966PTC005441. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹2.20 M.

It upholds a compliant status. Its leadership includes Ramkumar Krishnamurthy Anekar (Director), Rajiv Krishnamurthy (Director), Ramesh Puthigai Krishnamurthy (Director). Past directors included Padmanoor Harihara Rao Rajendra Rao. It holds no open charges and ₹11.22 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 43, Main Rd, Velachery Post,Madras-42. Madras-42., Madras-42., Tamil Nadu, 600042.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TN1966PTC005441

  • Registration Number

    005441

  • Incorporation Date

    06 August 1966

  • Authorized Capital

    ₹7.50 M

  • Paid-Up Capital

    ₹2.20 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 7.50 M
  • Paid Up Capital ₹ 2.20 M
  • Company Age 59 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 11.22 Cr
  • Revenue Growth **** 6.06%
  • Profit Growth **** -88.63%
  • Ebitda **** -56.20%
  • Net Worth 0.38%
  • Total Assets **** 1.29%
Company report

Citadel Fine Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Citadel Fine Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Citadel Fine Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ramkumar Krishnamurthy Anekar Director 05 Oct 2005 Current
Rajiv Krishnamurthy Director 05 Oct 2005 Current
Ramesh Puthigai Krishnamurthy Director 01 Feb 1988 Current
Ranjan Rao Machina Director 21 Jun 1996 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Feb 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Citadel Fine Pharmaceuticals.

Citadel Fine Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 6.06% increase. The company also saw a substantial fall in profitability, with a 88.63% decrease in profit. The company's net worth moved up by a moderate rise of 0.38%.

Citadel Fine Pharmaceuticals revenue growth over time
Citadel Fine Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 6.06%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 1.29%
*******
*******
*******
*******
Profit or Loss
*******
 -88.63%
*******
*******
*******
*******
Net Worth
*******
 0.38%
*******
*******
*******
*******
EBITDA
*******
 -56.20%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Citadel Fine Pharmaceuticals?

In 2020, Citadel Fine Pharmaceuticals had a promoter holding of 13.14% and a public holding of 86.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹112,159,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 11.18 Cr
  • The Karnataka Bank Ltd : 0.03 Cr
  • The Karnaka Bank Ltd : 0.01 Cr
Latest Charge Details
Date Lender Amount Status
26 Apr 2003 State Bank Of India ₹2.00 Cr Satisfied
15 Mar 1997 State Bank Of India ₹1.92 Cr Satisfied
25 Feb 1995 State Bank Of India ₹2.10 Cr Satisfied
30 Mar 1992 State Bank Of India ₹1.80 Cr Satisfied
26 Apr 1990 State Bank Of India ₹1.13 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Citadel Fine Pharmaceuticals?

Unlock and access historical data on people associated with Citadel Fine Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Citadel Fine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citadel Fine Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Citadel Fine Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Citadel Fine Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Citadel Fine Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.

  • Charges

    A charge registered on 17 Apr 1969 via Charge ID 90295644 with The Karnataka Bank Ltd was fully satisfied on 19 Jul 2008. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 09 Jan 1967 via Charge ID 90297257 with The Karnaka Bank Ltd was fully satisfied on 19 Jul 2008. was documented.

  • Charges

    A charge registered on 26 Apr 2003 via Charge ID 90295454 with State Bank Of India was fully satisfied on 24 Jun 2008. was recorded as a recent event.

  • Charges

    A charge registered on 15 Mar 1997 via Charge ID 90295568 with State Bank Of India was fully satisfied on 24 Jun 2008. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Citadel Fine Pharmaceuticals Private Limited?

The CIN of Citadel Fine Pharmaceuticals Private Limited is U24231TN1966PTC005441.

Where is Citadel Fine Pharmaceuticals Private Limited headquartered?

Citadel Fine Pharmaceuticals Private Limited is headquartered at 43, Main Rd, Velachery Post,Madras-42. Madras-42., Madras-42., Tamil Nadu, 600042.

When was Citadel Fine Pharmaceuticals Private Limited incorporated?

Citadel Fine Pharmaceuticals Private Limited was incorporated on 06 August 1966.

Who are the current directors of Citadel Fine Pharmaceuticals Private Limited?

The current directors of Citadel Fine Pharmaceuticals Private Limited are

What is the primary industry of Citadel Fine Pharmaceuticals Private Limited?

The primary industry of Citadel Fine Pharmaceuticals Private Limited is Hospital And Medical Care.

Is Citadel Fine Pharmaceuticals Private Limited a listed company?

Citadel Fine Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Citadel Fine Pharmaceuticals Private Limited?

The authorized capital of Citadel Fine Pharmaceuticals Private Limited is ₹7.50 M, and the paid-up capital is ₹2.20 M.

What is the compliance status of Citadel Fine Pharmaceuticals Private Limited?

The compliance status of Citadel Fine Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available